Lewy body dementia, dementia caused by abnormal protein deposits called Lewy bodies, is diagnosed differently from Alzheimer's by its focus on movement, sleep, hallucinations and alertness, not just memory. Doctors look for a distinct pattern of attention and visual problems plus specific Lewy biomarkers rather than relying on memory loss alone. Diagnosis starts with history, physical and neurological exams, thinking and movement tests, blood work and brain scans that rule out other causes. According to the Cleveland Clinic diagnosis guide, no single clinical test proves Lewy body dementia during life, and confirmation requires finding Lewy bodies at autopsy.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How is early thinking change different?
- What clinical signs support the diagnosis?
- Which scans and sleep tests help?
- Why do timing and mixed disease matter?
How is early thinking change different?
Early Lewy body dementia often impairs attention, visual perception and planning skills first. Memory loss is less prominent at the start. The Alzheimer's Association describes this contrast, with Alzheimer's typically beginning with clear short-term memory loss.
That difference shapes the questions doctors ask. They test how well a person sustains attention, follows multi-step tasks and interprets what they see. They also ask family members about blank stares, daytime sleepiness and sudden confusion.
What clinical signs support the diagnosis?
Doctors diagnose probable dementia with Lewy bodies when dementia occurs with at least two core features, or one core feature plus an indicative biomarker. The MSD Manual lists the standard in its MSD Manual diagnostic criteria as fluctuating attention and alertness, recurrent well-formed visual hallucinations, REM sleep behavior disorder and parkinsonism.
The four core features to track are: Bring dated notes and videos when safe. Concrete examples help the doctor separate brief fluctuations from constant forgetfulness.
- shifts in attention, alertness and thinking across hours or days
- clear, detailed visual hallucinations that recur
- acting out dreams with shouting, grabbing or falling from bed
- slow movement, stiffness, tremor or shuffling walk
Which scans and sleep tests help?
Memory checks and routine brain scans alone cannot separate the two diseases. Doctors add tests that detect Lewy-related changes in brain chemistry, heart nerves and sleep. The MSD Manual identifies reduced dopamine transporter uptake in the basal ganglia on DaT SPECT or PET as an indicative biomarker.
One core feature plus this result can support probable disease. The DLB Consortium consensus report identifies two other supports: abnormal low-uptake iodine-123 MIBG heart imaging showing sympathetic nerve loss, and overnight sleep study showing REM sleep without normal muscle paralysis. Neither test belongs in routine Alzheimer's workup.
Why do timing and mixed disease matter?
Timing helps separate related disorders. The Alzheimer's Association professional guidance states that dementia starting before or within one year of parkinsonism is classified as dementia with Lewy bodies, while dementia starting well after established Parkinson's disease is Parkinson's disease dementia.
Overlap remains common because many brains hold more than one disease process. The NIH 2025 dementia research progress report finds Lewy-body pathology combined with Alzheimer's pathology in about 30 percent of Alzheimer's cases. Ask whether sleep history, hallucination review and dopamine imaging were considered before accepting an Alzheimer's label.
